JY
CELG.RT

Jeff Yass’s Bristol-Myers Squibb Rights CELG.RT Stock Holding History

Jeff Yass’s Portfolio CELG.RT Stock Details CELG.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,115
Closed -$834 – 12447
2025
Q3 		$834 Sell
25,115
-11,987
-32% -$392 ﹤0.01% 12205
2025
Q2 		$928 Buy
+37,102
New +$1.13K ﹤0.01% 12511
2024
Q4 		– Sell
-113,375
Closed -$5.44K – 12268
2024
Q3 		$5.44K Sell
113,375
-8,800
-7% -$349 ﹤0.01% 11752
2024
Q2 		$5.01K Buy
122,175
+44,117
+57% +$2.34K ﹤0.01% 11820
2024
Q1 		$4.29K Sell
78,058
-11,399
-13% -$688 ﹤0.01% 11961
2023
Q4 		$8.05K Buy
89,457
+21,617
+32% +$1.84K ﹤0.01% 12091
2023
Q3 		$6.45K Sell
67,840
-5,734
-8% -$586 ﹤0.01% 11757
2023
Q2 		$8.09K Buy
73,574
+6,238
+9% +$706 ﹤0.01% 11786
2023
Q1 		$8.48K Buy
67,336
+17,150
+34% +$2.28K ﹤0.01% 12230
2022
Q4 		$5.92K Sell
50,186
-14,714
-23% -$1.98K ﹤0.01% 12020
2022
Q3 		$9K Buy
64,900
+8,998
+16% +$1.25K ﹤0.01% 12796
2022
Q2 		$8K Buy
55,902
+6,672
+14% +$882 ﹤0.01% 12551
2022
Q1 		$7K Buy
49,230
+13,141
+36% +$2.14K ﹤0.01% 12786
2021
Q4 		$7K Buy
+36,089
New +$6.75K ﹤0.01% 12966
2020
Q4 		– Sell
-26,802
Closed -$10K – 11048
2020
Q3 		$10K Sell
26,802
-18
-0.1% -$8 ﹤0.01% 10415
2020
Q2 		$11K Buy
26,820
+13,952
+108% +$6.32K ﹤0.01% 9974
2020
Q1 		$6K Buy
+12,868
New +$7.19K ﹤0.01% 10091

Other funds holding CELG.RT

TCA
Transcend Capital Advisors Madison, New Jersey $1.48B AUM 25.55% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PCA
Purkiss Capital Advisors Ridgefield, Connecticut $263M AUM 29.59% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Jeff Yass's CELG.RT Position: Q4 2025 in Review

Jeff Yass sold out of Bristol-Myers Squibb Rights (CELG.RT) in Q4 2025, closing a stake of 25,115 shares — an estimated $834 sold.

Jeff Yass first reported a position in CELG.RT in Q1 2020 and held it in 17 quarters. The position peaked at $11K in Q2 2020. 18 funds tracked by Wall St. Rank hold CELG.RT as of Q4 2025.

  • Jeff Yass reported no remaining Bristol-Myers Squibb Rights position as of Q4 2025 after selling out during the quarter.
  • Jeff Yass sold 25,115 Bristol-Myers Squibb Rights shares in Q4 2025, an estimated $834.
  • Jeff Yass first reported a position in Bristol-Myers Squibb Rights in Q1 2020 and held it in 17 quarters.
  • Jeff Yass's Bristol-Myers Squibb Rights position peaked at $11K in Q2 2020.
  • 18 funds tracked by Wall St. Rank held Bristol-Myers Squibb Rights as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.